Inspire Medical Systems
INSP
About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Employees: 1,246
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
0.14% less ownership
Funds ownership: 114.68% [Q1] → 114.54% (-0.14%) [Q2]
4% less first-time investments, than exits
New positions opened: 51 | Existing positions closed: 53
8% less call options, than puts
Call options by funds: $15.4M | Put options by funds: $16.7M
8% less repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 138
2% less funds holding
Funds holding: 359 [Q1] → 353 (-6) [Q2]
20% less capital invested
Capital invested by funds: $5.46B [Q1] → $4.39B (-$1.08B) [Q2]
67% less funds holding in top 10
Funds holding in top 10: 6 [Q1] → 2 (-4) [Q2]
Research analyst outlook
11 Wall Street Analysts provided 1 year price targets over the past 3 months
11 analyst ratings
Evercore ISI Group
Daniel Markowitz
|
$150
|
Outperform
Initiated
|
2 Sep 2025 |
Leerink Partners
Mike Kratky
|
$97
|
Market Perform
Maintained
|
15 Aug 2025 |
Truist Securities
Richard Newitter
|
$125
|
Hold
Downgraded
|
5 Aug 2025 |
Lake Street
Frank Takkinen
|
$150
|
Buy
Maintained
|
5 Aug 2025 |
Wells Fargo
Larry Biegelsen
|
$101
|
Equal-Weight
Maintained
|
5 Aug 2025 |
UBS
Danielle Antalffy
|
$230
|
Buy
Maintained
|
5 Aug 2025 |
RBC Capital
Shagun Singh
|
$180
|
Outperform
Maintained
|
5 Aug 2025 |
Piper Sandler
Adam Maeder
|
$150
|
Overweight
Maintained
|
5 Aug 2025 |
Stifel
Jonathan Block
|
$140
|
Hold
Maintained
|
5 Aug 2025 |
JP Morgan
Robbie Marcus
|
$110
|
Neutral
Downgraded
|
5 Aug 2025 |
Morgan Stanley
Kallum Titchmarsh
|
$182
|
Overweight
Maintained
|
15 Jul 2025 |
Financial journalist opinion
Based on 19 articles about INSP published over the past 30 days